Digital Omicron Detection using Unscripted Voice Samples from Social Media ========================================================================== * James T. Anibal * Adam J. Landa * Hang T. Nguyen * Alec K. Peltekian * Andrew D. Shin * Miranda J. Song * Anna S. Christou * Lindsey A. Hazen * Jocelyne Rivera * Robert A. Morhard * Ulas Bagci * Ming Li * David A. Clifton * Bradford J. Wood ## Summary The success of artificial intelligence in clinical environments relies upon the diversity and availability of training data. In some cases, social media data may be used to counterbalance the limited amount of accessible, well-curated clinical data, but this possibility remains largely unexplored. In this study, we mined YouTube to collect voice data from individuals with self-declared positive COVID-19 tests during time periods in which Omicron was the predominant variant1,2,3, while also sampling non-Omicron COVID-19 variants, other upper respiratory infections (URI), and healthy subjects. The resulting dataset was used to train a DenseNet model to detect the Omicron variant from voice changes. Our model achieved 0.85/0.80 sensitivity/specificity in separating Omicron samples from healthy samples and 0.76/0.70 sensitivity/specificity in separating Omicron samples from symptomatic non-COVID samples. In comparison with past studies, which used scripted voice samples, we showed that leveraging the intra-sample variance inherent to unscripted speech enhanced generalization. Our work introduced novel design paradigms for audio-based diagnostic tools and established the potential of social media data to train digital diagnostic models suitable for real-world deployment. ## 1. Introduction COVID-19 is routinely detected and confirmed through polymerase chain reaction (PCR) using nasal or throat swabs; however, turnaround time and resource costs pose a challenge for testing in some settings. Some invasive home testing methods have been developed but can require expensive reagents and/or laboratory expertise, restricting accessibility. Moreover, these tests do not offer immediate results, which have become increasingly necessary as societies move towards “living with COVID”4. Serial testing practices have become common, in which reasonably sensitive at-home antigen tests are followed by more-specific PCR confirmation. Instant, non-invasive, and sensitive testing methods may be useful for suggesting confirmatory testing or to track the spread of variants with unique audio phenotypes. Prior AI methods have been unable to successfully detect pre-Omicron variants from unscripted or scripted human voice alone, or have been otherwise unsuitable for deployment (e.g., limited training data, poor generalization)5. Omicron variants, however, are typically milder and affect the upper airway more commonly than prior variants, often resulting in voice changes without a cough or other respiratory symptoms6. This presents an opportunity for targeting with AI methods, if robust datasets were available. Worldwide, various social media platforms have over 3.6 billion users, with expectations to exceed 4.4 billion by 20257. Over 500 hours of video are uploaded to YouTube alone every minute8. While often ignored, much of this data is available to researchers through Python libraries provided by social media companies. Such data more accurately portrays noisy, unscripted “real-world” data, whose broad diversity supports generalizability. Our model was trained using this freely accessible data. Though annotation of training data was based upon prevalence assumptions and self-declaration instead of sequencing, these limitations contributed to the practicality and cost-effectiveness of the approach. As opposed to other methods that rely on lab results, AI-based classification tools using voice alone could be instant, accessible, cost-effective, and deployable in real-world settings. There are numerous barriers to practical deployment of AI models for COVID-19 diagnostics. Prior attempts have failed due to training on extremely limited datasets, producing overfit models that do not generalize9. Existing models for acoustic, AI-driven diagnostics have also been limited due to a reliance on short, structured samples collected in controlled, scripted environments. In this report, we broadly applied dataset design and audio-based deep learning methodologies in the context of Omicron classification. ### Contributions 1. An AI system was constructed using social media data, with training and validation strategies designed for real-world clinical settings. This improves upon prior social media AI efforts which simply facilitated narrow tasks in controlled settings involving frequent users of social media. 2. A new framework for rapid diagnostic tools from voice/audio data was designed to emphasize longer samples and unscripted collection protocols. This strategy relied on the diversity of the input data to better prepare for real-world testing environments. A convolutional neural network (CNN) model trained on long, unscripted samples showed improved generalization in comparison to prior work on short, scripted speaking inputs, as well as in our comparative experiments involving short, unscripted inputs. 3. The first non-invasive model for instant Omicron detection was developed using training data that included past variants, recent subvariants, healthy controls, and other respiratory illnesses. Our data was compiled from a diverse array of settings and recordings, containing over 28 hours of unscripted audio from people posting with self-declared Omicron. This is several orders of magnitude greater than previous efforts. Identification of voice changes in speakers with self-declared Omicron showed that unscripted recordings may be sufficient for detecting Omicron COVID-19, which is a change from past variants. 4. Acoustic biomarkers for COVID-19 were shown to change between non-Omicron (primarily Alpha/Delta) variants (lower respiratory symptoms) and the milder Omicron variant (upper respiratory symptoms). Models trained on voice data from pre-Omicron variants experienced a decrease in both sensitivity and specificity when validated on Omicron test data. This result emphasized the necessity of **variant-specific methods for testing**, or continual learning techniques that adapt as pandemics evolve over time. ## 2. Related Work ### 2.1 Social Media Data for Clinical Tasks Cost-effective data collection, curation, annotation, and augmentation are critical for enabling AI to track or predict illness. Social media is an expansive source of information that does not rely on intricate searching mechanisms or filtered, delayed reporting, potentially facilitating epidemiological surveillance. Several existing diagnostic models have utilized social media data. A deep learning model trained on Tweets was more predictive of atherosclerotic heart disease mortality than a conventional mechanistic input-based model combining demographic and health risk factors10. Additional methods have extracted textual and visual features from Tweets to predict and classify mental health status11,12,13. These models, however, were only useful for active social media users. Other social media platforms have also been used as data sources for biomedical applications, though less frequently than Twitter. Manual analysis of YouTube home videos by non-clinical raters was able to detect and classify autism in children with high performance14. YouTube audio, visual, and search-history data have also successfully detected mental illnesses including depression and OCD15,16. ### 2.2 AI for COVID-19 Testing AI methodologies have been applied to numerous COVID-19 datasets to develop deployable diagnostic tools. Coughing and breathing changes associated with COVID-19 may have unique features that might be useful for classification, or differentiation from other upper respiratory illnesses or infections (URIs). Related work should, however, be contextualized using the criteria outlined by Han et al., which pointed out methodological flaws such as mixing training/testing data, exclusion of non-COVID URIs, and overfitting on small datasets5. Prior work has also typically lacked stratification by variant, instead considering “COVID” as a whole and assuming a generally consistent phenotype. Nonetheless, previous efforts highlighted the potential for voice-based diagnostic tools, especially given that COVID-19 breath sounds were characterized by unique time and frequency domain patterns17. A CNN-based model trained on forced-cough recordings in limited numbers of patients with and without COVID-19 was able to recognize COVID-19 with high sensitivity, even in otherwise asymptomatic subjects18. Audio-based technologies using cough sounds have also been deployed on a smartphone app for COVID-19 detection19,20,21,22,23. A binary classifier was able to differentiate COVID-19 speech from normal speech based on scripted telephone data24. Assessment of spectral features of speech alone in asymptomatic patients with and without COVID-19 yielded a true positive rate of 70%, though the likelihood of generalization was quite limited due to scripted collection and small sample size. In a dynamic pandemic such as COVID-19, crowdsourced datasets allowed for continuous and focused sample collection. “Coswara” is a database containing COVID-19 respiratory sound samples, including cough, breath, and scripted voice data25. Samples recorded and uploaded by volunteers on a smartphone or computer were divided into COVID and non-COVID cohorts26. Numerous researchers have used this database to train AI models for COVID-19 detection20,23,27. Such algorithms reported an accuracy of 97% on limited binary datasets, which notably excluded other respiratory illnesses28,29. Deep learning models trained on the “Sounds of COVID” dataset, which contained scripted samples, showed that voice alone performed poorly on pre-Omicron data (0.61 ROC-AUC)5. Further, most studies focused on multi-input models without specifying the variant (via sequencing or demographic statistics). ## 3. Methods This study was performed as human subjects research with Institutional Research Board approval and waiver of subject consent. The analysis, supervised training, validation, and testing pipeline for the Omicron voice detection model is outlined (Fig. 1). ![Figure 1:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/06/2022.09.13.22279673/F1.medium.gif) [Figure 1:](http://medrxiv.org/content/early/2022/10/06/2022.09.13.22279673/F1) Figure 1: Workflow for YouTube data preprocessing. (1) Data was collected from YouTube and annotated based on user declarations. (2) A U-Net model was used to separate voice from music and other background noise. (3) A voice activity detector (VAD), built with Gaussian mixture models removed extended periods of silence. (4) The remaining, cleaned voice data was converted into a spectrogram. ![Figure 2:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/06/2022.09.13.22279673/F2.medium.gif) [Figure 2:](http://medrxiv.org/content/early/2022/10/06/2022.09.13.22279673/F2) Figure 2: Workflow for training and validation of Omicron detection pipeline. (1) Audio recordings were split into segments and converted to spectrograms; (2) DenseNet model was trained on the spectrograms; (3) trained model was used to predict if segments in a testing dataset were positive or negative for Omicron COVID-19 (majority vote was used to assign a label). ### 3.1 Data Collection Audio samples were mined from YouTube searches and annotated by cohort based on self-declaration and presumptive correlation with epidemiological data. 1. COVID-19 – Omicron variant (presumed by dates, including both symptomatic and asymptomatic cases) 2. COVID-19 – non-Omicron variant (presumed by dates, including both symptomatic and asymptomatic cases) 3. Symptomatic, non-COVID upper respiratory illnesses and infections (URI) 4. Presumably healthy or non-acutely ill (asymptomatic). A series of heuristics were used to identify relevant videos. For example, if the user said, “I have COVID” or “I tested positive” during a time in which Omicron was the dominant variant, the audio sample was labeled as “Omicron”. We excluded videos that contained low-quality audio or featured multiple speakers. For the URI cohort, we excluded videos where there were no obvious respiratory symptoms. YouTube videos were annotated by cohort and manually verified to ensure accurate labeling. Since the data mining procedure was standardized but not comprehensive, future studies might benefit from automated mining procedures for dataset expansion. All Omicron videos were from December 20th, 2021 – August 1st, 2022. Omicron was designated a “variant of concern” on November 26th, 2021 by the WHO, and was estimated to be the dominant variant in the US by late December 202130,31. Omicron was identified as the dominant variant globally, accounting for > 98% of sequences shared on GISAID after February 20222,32. The BA.1 and BA.2 lineages were most common between December 2021 – June 2022, with BA.4/BA.5 becoming more prevalent in July 202233. No sequencing was recorded. ### 3.2 Data Preprocessing Raw audio samples extracted from YouTube videos were noisy, often containing background noise, long periods of silence, or low-resolution audio. To reduce potential sources of confusion, a preprocessing pipeline was implemented: 1. **Audio Denoising:** Following audio quality assessments, “noisy” sound was removed using semi-supervised machine learning methods developed by Dolby and accessed through Dolby Media libraries for Python34. 2. **Removal of Background Noise and Silence:** Background noise was removed via a U-Net convolutional neural network architecture35. Extended periods of silence were removed via a voice activity detector that leveraged Gaussian mixture models to identify non-speaking regions36. 3. **Conversion into Mel spectrograms:** Samples were converted into a 3-channel matrix, corresponding to 3 Mel spectrograms generated with different window sizes and hop lengths. Mel spectrograms represented sound as frequency over time with frequency values converted to the Mel scale, which represents pitch based on how the human ear perceives loudness. This approach ensured that each channel contained different frequency and time information (equivalent to resolution in a standard image representation), providing the model with maximal context during training37. ### 3.3 Augmentation In audio-based diagnostics, there is minimal value in positional context. While past work has shown that sounds have variable effectiveness as disease predictors, we further assumed that relevant digital biomarkers of laryngitis should be detectable within a 10 second interval38. Our simple data augmentation strategy relied on the positional invariance of speech samples and the reduced need for modeling long-term dependencies, in the context of laryngitis. We aimed to use the natural diversity of speech to enhance the generalizability of our model and reduce the impact of class imbalance. For each audio recording, we considered the set of possible transformations to be the result of dividing the sample into segments of length *n* seconds. Time and frequency masking were applied to each segment (via SpecAugment) prior to input into the CNN model, which is explained in section 3.439. ### 3.4 DenseNet Convolutional neural networks (CNNs) utilize the convolution operation to model spatial relationships in matrices (e.g., images or spectrograms). These representations are generally input into a standard feed-forward neural network and mapped onto an outcome or embedding vector. In most cases, individual layers are connected only to the subsequent layer. DenseNet introduced a new framework wherein each layer was connected to all subsequent layers in a “Dense Block”, while allowing for multiple Dense Blocks within the same network40. These blocks were connected to each other via convolution and pooling layers which structured the outputs of one block as inputs for the following block. This approach had multiple advantages for complex tasks, including improved feature propagation and reuse. The DenseNet model was chosen due to the scalability of the architecture and high top-1 accuracy value on the complex ImageNet dataset, indicating that it had learned a generalizable representation of images through key shapes/features. A pre-trained model was chosen based on prior work which reported that CNN models pre-trained on ImageNet achieved superior performance on audio data compared to randomly initialized models37,41. Other recent architectures (e.g., Vision Transformer) can also be used in our model-invariant system42. ## 4. Experimental Design Experiments were performed to assess the potential of social media data for training models to complete diagnostic tasks. We also assessed the generalization capacity gained from using the long, free-response inputs as a component of the data augmentation strategy alongside SpecAugment (compared to short, standardized inputs). The reported performance metrics were mean values from 6-fold cross validation used in each experiment (Table 2). ### 4.1 YouTube Dataset Our YouTube dataset contained 183 subjects with Omicron (28.39 hours), 120 with pre-Omicron COVID-19 (22.84 hours), 138 with symptomatic non-COVID URIs (8.09 hours), and 192 that were asymptomatic healthy (33.90 hours). Dataset statistics are listed in Table 1 to emphasize the additional information gained from collecting longer samples of unscripted voice data. View this table: [Table 1:](http://medrxiv.org/content/early/2022/10/06/2022.09.13.22279673/T1) Table 1: Comparative statistics for two common COVID-19 Voice Datasets. Statistics from Coswara were listed based on the amount of data at the time of access (May 18th, 2022). We also excluded any data points which did not meet the criteria for inclusion in the Coswara database (e.g., multiple voices, indetectable audio). View this table: [Table 2:](http://medrxiv.org/content/early/2022/10/06/2022.09.13.22279673/T2) Table 2: Model performance on COVID-19 detection (including both Omicron data and non-Omicron data) with randomly selected test datasets from the YouTube dataset. To the best of our knowledge, the YouTube dataset currently contains the largest amount of voice data (in hours) for COVID-19 (all variants), the Omicron variants specifically, and, particularly, URI that were confirmed or self-declared non-COVID. This is in comparison to all publicly available COVID-19 voice/sounds datasets. The Coswara dataset contained samples which may be other upper respiratory infections but were not confirmed or self-declared as non-COVID25. We also noted that nearly half the 1,964 negative participants in the “Sounds of COVID” dataset had at least one “COVID” symptom, but many were unrelated to the upper respiratory system (e.g., fever, dizziness)5. In contrast, the YouTube dataset intentionally included illnesses that were designated non-Omicron based on self-declaration or date of posting. The samples were selected for the potential to impact the upper respiratory system, teaching the model to separate between non-COVID illnesses and Omicron. These URI included influenza, strep throat, cold, allergy attack, asthma, bronchitis, and others. Prior to training, we applied preprocessing and augmentation strategies to the dataset as described in sections 3.2-3.3. ### 4.2 DenseNet Model Training For supervised classification tasks involving voice samples, a cross-entropy loss function was used to fine-tune a pre-trained DenseNet. To address imbalances in the dataset, each batch was generated by oversampling the minority class. For each sample in the batch, a 2.5 second voice segment was selected randomly from the entire audio recording. #### 4.2.1 Classification of Omicron and Asymptomatic Healthy Subjects A DenseNet model was trained to identify healthy subjects (e.g., for testing asymptomatic individuals prior to attending populated events) through the binary classification task of separating asymptomatic healthy voices from all Omicron subjects. #### 4.2.1 Classification of Omicron and Symptomatic URI Subjects For further classification of users presenting with upper-respiratory symptoms, the model was trained to use voice data to separate Omicron subjects from symptomatic subjects with other, non-COVID URIs. #### 4.2.3 Model Training with Non-Omicron COVID-19 Data We trained a model with non-Omicron data and attempted to classify COVID/URI and COVID/healthy from test sets containing only Omicron and non-COVID subjects (no other variants were present). This was done to highlight changes in disease phenotype over time and show the need for variant-specific digital testing methods. #### 4.2.4 Model Training with Single Segments To demonstrate the importance of collecting longer time-series datasets, we repeated the Omicron detection tasks (4.2.1-4.2.2) with short, randomly selected segments (one per sample) from the YouTube dataset. The same segment was used throughout the training process – the remainder of the data was not shown to the model. Due to model overfitting, we froze the base layers of the DenseNet and fine-tuned only the classification head. ### 4.3 Model Validation When validating on a blind test dataset, sensitivity and specificity were calculated on a per-sample basis. Each sample was divided into *n*-second segments as described in section 3.3. For samples that could be split into multiple segments, a majority vote was used to assign the final label (“positive” or “negative”). This approach was used to facilitate real-world deployment where the user might be prompted to supply at minimum 30 seconds of audio, thereby reducing the risk of random noise or vocal shifts that could obscure relevant digital biomarkers. ## 5. Experimental Results ### 5.1 Digital Testing on the YouTube Dataset #### 5.1.1 Extended Voice Samples Our model was tested on the YouTube dataset to perform classification tasks (Table 2). Voice changes were used to detect the Omicron variant on “real-world” data from YouTube. Model performance was 85% sensitive and 80% specific for classification of Omicron subjects and asymptomatic healthy subjects. Notably, the model yielded a sensitivity of 76% and a specificity of 70% on the symptomatic testing task of separating Omicron samples from other, symptomatic URI samples. These findings indicate the existence of an Omicron-specific laryngitis. This finding suggests that models trained on real-world voice data may have relevance for symptomatic testing, beyond identifying healthy, asymptomatic voices. Our model was further tested on the YouTube dataset to determine if voice changes caused by Omicron represented a detectable shift in phenotype compared to Alpha/Delta variants, which often presented with lower respiratory symptoms. Similar to past work, the results show that voice data alone does not facilitate the separation of pre-Omicron COVID-19 samples from asymptomatic healthy samples (84% sensitivity / 58% specificity). The limited signal verifies the limited acoustic biomarkers in subjects with the pre-Omicron variants of COVID-19. The improved results on the COVID/URI classification task (74% sensitivity / 70% specificity) are likely due to the model detecting voice changes or other respiratory symptoms in the patients with URI. This is in contrast with the pre-Omicron COVID-19 patients, which seem to have similar voices to healthy asymptomatic subjects. Voice data was more effective at detecting the Omicron variant in both the healthy/COVID-19 classification task (a difference in specificity of over 20%), and the COVID-19/other URI classification task. Furthermore, our results show that there is performance degradation for the Omicron/URI task (5-7% reduction in both sensitivity and specificity) when a non-Omicron model is validated on Omicron test data. This is in comparison to an Omicron-trained model that is validated on Omicron test data. The likely cause of this result is that the model does not learn to recognize the Omicron-specific laryngitis that may be an important feature for classification. There was a similar performance decline (5-10%) on the healthy/Omicron binary classification task (pre-Omicron training, Omicron testing), which is, once again, likely resulting from the model being boosted by the presence of “Omicron laryngitis” in the training data. We observe that the model for healthy/pre-Omicron classification achieves better performance on Omicron test data than the non-Omicron test data. We speculate that this is due to the limited presence of general laryngitis in the training data, which can be transferred to Omicron test data, where upper respiratory symptoms are common. For the non-Omicron test data, laryngitis in the test data, statistically, should be much more sporadic. #### 5.1.2 Single-segment Voice Samples We trained our model to complete both the Omicron detection tasks on the same subjects, with only one segment per subject in the dataset. Despite the use of multiple data augmentation techniques, our results (Table 3) showed a decrease in both sensitivity and specificity (10-20%) when only a single segment was used, demonstrating the importance of collecting longer time-series data, even if there are a limited number of subjects. In addition, these extended data points may reduce the risk of error in a real-world digital testing solution. When performing inference, the model can check multiple independent segments over a 30+ second input (faster than current rapid testing solutions) to reduce the risk of testing on a corrupted or unrepresentative data point. View this table: [Table 3:](http://medrxiv.org/content/early/2022/10/06/2022.09.13.22279673/T3) Table 3: Model performance on Omicron detection with a single segment per sample. ## 6. Discussion In this report, we show that: 1. Public online data, including unscripted social media data, had potential epidemiologic value in pandemics, with audio information that could be utilized by AI models for applications not specific to social media/Internet users. 2. In contrast with past variants, voice change was a predictor of the Omicron variant, which was often milder and lacked a cough. Omicron samples were distinguishable not only from healthy voices, but also from voices with other self-declared upper respiratory illness and infections. 3. Models trained on pre-Omicron data alone showed a decline in performance when validated on test datasets containing Omicron samples. This demonstrates the importance of testing methods which are continuously updated and validated with variant-specific data. This is relevant for future pandemic preparedness, where perhaps deep learning may play a more meaningful role. 4. Models trained on longer, unscripted audio samples achieved superior performance compared to shorter scripted inputs used in prior work (e.g., counting to 20) and shorter unscripted inputs (section 5.1.2). Lengthy voice samples improved model performance due to the diversity of unscripted data. We introduced the “YouTube COVID-19 voice dataset”, which contains over one full day of audio data corresponding to the Omicron variant, and similar quantities for non-Omicron COVID-19 and healthy controls. The dataset also includes over 8 hours of data from other upper respiratory illness and infection, improving upon other COVID-19 audio datasets which were noisy, unbalanced, and contained undiagnosed URI data (unconfirmed COVID negativity). This comparison underscores the value of retrospective data collection from public social media in real-world settings, despite the lack of ground truth verification. Voice changes may represent a biomarker for Omicron. The exact underlying mechanism for characteristic audiogram alterations may be due to local laryngitis; however, the central nervous system is also capable of controlling pitch in speech43,44. ### 6.1 Real-World Deployment Potential future directions for this work include dataset expansion through improved mining methods, implementation of a smartphone/web-app system for day-to-day testing or user-specific customized models, and development of continual learning. Furthermore, regular pre-screening in at-risk populations could be used to define the temporal/geographic dynamics of voice changes from variants as a virus evolves. However, model deployment, stability, and impact currently remain highly speculative due to the limited size of samples from other URIs, lack of PCR confirmation testing and sequencing, and cohort annotations based on assumption. ## 7. Conclusion Digital epidemiology is provocative and understudied in the context of public online data and social media data; however, its wide availability raises new questions for privacy security, regulation, ethics, and real-world validation. Unscripted social media audio data may inherently be more diverse (and ultimately lead to more generalizable models) than narrow-intent scripted data. For symptomatic illnesses, these indicators may be more accurately reflected in longer samples. Even without ground truth from sequencing, the results achieved by this early effort at Omicron detection merit further evaluation or smartphone app assessment in specific controlled public health settings with unmet needs. Despite limitations, this work highlights the unique presentation of laryngitis in patients with the COVID-19 Omicron variant. Social media as a source of unscripted audio data may enable new frameworks to facilitate variant-specific testing. ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Disclosures / Conflicts of Interest The content of this manuscript does not necessarily rflect the views, policies, or opinions of the National Institutes of Health (NIH), the U.S. Department of Health and Human Services, the U.K. National Health Service, the U.K. National Institute for Health Research, the U.K. Department of Health, InnoHK – ITC, or the University of Oxford. The mention of commercial products, their source, or their use in connection with material reported herein is not to be construed as an actual or implied endorsement of such products by the U.S. government. Opinions expressed are those of the authors, not necessarily the NIH. NIH may own intellectual property in the field. NIH and BJW receive royalties for licensed patents from Philips, unrelated to this work. FDA and CE Mark “off-label use of devices may be discussed or implied. BW is Principal Investigator on the following CRADA’s = Cooperative Research & Development Agreements, between NIH and industry: Philips, Philips Research, Celsion Corp, BTG Biocompatibles / Boston Scientific, Siemens, NVIDIA, XACT Robotics. Promaxo (in progress). The following industry partners also support research in CIO lab via equipment, personnel, devices and/ or drugs: 3T Technologies (devices), Exact Imaging (data), AngioDynamics (equipment), AstraZeneca (pharmaceuticals, NCI CRADA), ArciTrax (devices and equipment), Imactis (Equipment), Johnson & Johnson (equipment), Medtronic (equipment), Theromics (Supplies), Profound Medical (equipment and supplies), QT Imaging (equipment and supplies). ## Author Contributions JTA, BJW, DAC, ML, UB designed and supervised the research. AJL, HTN, AKP, and ADS collected, annotated, and curated data. JTA and AJL designed and implemented the preprocessing pipeline. JTA implemented AI models and performed experiments. JTA, BJW, AJL, MJS, ASC, LAH, JR, and RAM wrote/edited the manuscript and outlined future work. JTA, BJW and LAH managed the collaborative components of the project and completed IRB requirements. ## Funding This work was supported by the NIH Center for Interventional Oncology and the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and the National Institute of Biomedical Imaging and Bioengineering, via intramural NIH Grants Z1A CL040015 and 1ZIDBC011242.Work also supported by the NIH Intramural Targeted Anti-COVID-19 (ITAC) Program, funded by the National Institute of Allergy and Infectious Diseases. DAC was supported in part by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), and in part by an InnoHK Project at the Hong Kong Centre for Cerebro-cardiovascular Health Engineering (COCHE). DAC is also a funded Investigator in the Pandemic Sciences Institute, University of Oxford, Oxford, UK. ## Footnotes * This version of the manuscript has been revised to contain the following: additional experiments to demonstrate the importance of variant-specific analysis and testing/diagnostic methods in dynamic pandemic environments. * Received September 13, 2022. * Revision received October 6, 2022. * Accepted October 6, 2022. * © 2022, Posted by Cold Spring Harbor Laboratory This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/) ## References 1. 1.Hodcroft, E. B. CoVariants: SARS-CoV-2 Mutations and Variants of Interest. [https://covariants.org/](https://covariants.org/) (2021). 2. 2.Elbe, S., & Buckland-Merrett, G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Global Challenges 1(1), 33–46 (2017). 3. 3.Leatherby, L. What the BA.5 Subvariant Could Mean for the United States. The New York Times [https://www.nytimes.com/interactive/2022/07/07/us/ba5-covid-Omicron-subvariant.html](https://www.nytimes.com/interactive/2022/07/07/us/ba5-covid-Omicron-subvariant.html) (2022). 4. 4.Ye, Q., Lu, D., Zhang, T., Mao, J., & Shang, S. Recent advances and clinical application in point-of-care testing of SARS-CoV-2. Journal of Medical Virology 94(5), 1866–1875 (2022). 5. 5.Han, J. et al. (2022). Sounds of COVID-19: exploring realistic performance of audio-based digital testing. Npj Digital Medicine 5(1), 16 (2022). 6. 6.Usman, M., Gunjan, V. K., Wajid, M., Zubair, M., & Siddiquee, K. N. Speech as a Biomarker for COVID-19 Detection Using Machine Learning. Computational Intelligence and Neuroscience [https://doi.org/10.1155/2022/6093613](https://doi.org/10.1155/2022/6093613) (2022). 7. 7.Dixon, S. Number of social media users worldwide from 2018 to 2022, with forecasts from 2023 to 2027. Statista [https://www.statista.com/statistics/278414/number-of-worldwide-social-network-users/](https://www.statista.com/statistics/278414/number-of-worldwide-social-network-users/) (2022). 8. 8.Ceci, L. Hours of video uploaded to YouTube every minute as of February 2020. Statista [https://www.statista.com/statistics/259477/hours-of-video-uploaded-to-youtube-every-minute/](https://www.statista.com/statistics/259477/hours-of-video-uploaded-to-youtube-every-minute/) (2022). 9. 9.Roberts, M. et al. Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans. Nature Machine Intelligence 3(3), 199– 217 (2021). 10. 10.Eichstaedt, J. C. et al. Psychological Language on Twitter Predicts County-Level Heart Disease Mortality. Psychological Science 26(2), 159–169 (2015). [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/0956797614557867&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25605707&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F06%2F2022.09.13.22279673.atom) 11. 11.Sadasivuni, S. T., & Zhang, Y. Using Gradient Methods to Predict Twitter Users’ Mental Health with Both COVID-19 Growth Patterns and Tweets. 2020 IEEE International Conference on Humanized Computing and Communication with Artificial Intelligence (HCCAI), 65–66 (2020). 12. 12.Gui, T. et al. Cooperative Multimodal Approach to Depression Detection in Twitter. Proceedings of the AAAI Conference on Artificial Intelligence 33(01), 110–117 (2019). 13. 13.Chatterjee, M., Samanta, P., Kumar, P., & Sarkar, D. Suicide Ideation Detection using Multiple Feature Analysis from Twitter Data. 2022 IEEE Delhi Section Conference (DELCON), 1–6 (2022). 14. 14.Fusaro, V. A. et al. The Potential of Accelerating Early Detection of Autism through Content Analysis of YouTube Videos. PLOS ONE 9(4), e93533 (2014). [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0093533&link_type=DOI) 15. 15.Zhang, B., Zaman, A., Silenzio, V., Kautz, H., & Hoque, E. The Relationships of Deteriorating Depression and Anxiety With Longitudinal Behavioral Changes in Google and YouTube Use During COVID-19: Observational Study. JMIR Ment Health 7(11), e24012 (2020). [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/24012&link_type=DOI) 16. 16.Abhishek, P., Gogoi, V., & Borah, L. Depiction of Obsessive-Compulsive Disorder in YouTube videos. Informatics for Health and Social Care 46(3), 256–262 (2021). 17. 17.Deshpande, G., & Schuller, B. W. COVID-19 Biomarkers in Speech: On Source and Filter Components. 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), 800–803 (2021). 18. 18.Laguarta, J., Hueto, F., & Subirana, B. COVID-19 Artificial Intelligence Diagnosis Using Only Cough Recordings. IEEE Open Journal of Engineering in Medicine and Biology 1, 275–281 (2020). 19. 19.Imran, A. et al. AI4COVID-19: AI enabled preliminary diagnosis for COVID-19 from cough samples via an app. Informatics in Medicine Unlocked 20, 100378 (2020). 20. 20.Pahar, M., Klopper, M., Warren, R., & Niesler, T. COVID-19 cough classification using machine learning and global smartphone recordings. Computers in Biology and Medicine 135, 104572 (2021). [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.compbiomed.2021.104572&link_type=DOI) 21. 21.Rahman, T. et al. QUCoughScope: An Intelligent Application to Detect COVID-19 Patients Using Cough and Breath Sounds. Diagnostics 12(4) (2022). 22. 22.Chen, Z. et al. Diagnosis of COVID-19 via acoustic analysis and artificial intelligence by monitoring breath sounds on smartphones. Journal of Biomedical Informatics 130, (2022). 23. 23.Alkhodari, M., & Khandoker, A. H. Detection of COVID-19 in smartphone-based breathing recordings: A pre-screening deep learning tool. PLOS ONE 17(1), 1–25 (2022). [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0262491&link_type=DOI) 24. 24.Ritwik, K. V. S., Kalluri, S. B., & Vijayasenan, D. COVID-19 Patient Detection from Telephone Quality Speech Data. Preprint at arXiv [https://doi.org/10.48550/ARXIV.2011.04299](https://doi.org/10.48550/ARXIV.2011.04299) (2020). 25. 25.Sharma, N. et al. Coswara—A Database of Breathing, Cough, and Voice Sounds for COVID-19 Diagnosis. Interspeech 2020 [https://doi.org/10.21437/interspeech.2020-2768](https://doi.org/10.21437/interspeech.2020-2768) (2020). 26. 26.Sharma, N. K. et al. Towards sound based testing of COVID-19—Summary of the first Diagnostics of COVID-19 using Acoustics (DiCOVA) Challenge. Computer Speech & Language 73, 101320 (2022). 27. 27.Chowdhury, N. K., Kabir, M. A., Rahman, Md. M., & Islam, S. M. S. Machine learning for detecting COVID-19 from cough sounds: An ensemble-based MCDM method. Computers in Biology and Medicine 145, 105405 (2022). 28. 28.Verde, L. et al. Exploring the Use of Artificial Intelligence Techniques to Detect the Presence of Coronavirus Covid-19 Through Speech and Voice Analysis. IEEE Access 9, 65750–65757 (2021). 29. 29.Verde, L., de Pietro, G., & Sannino, G. Artificial Intelligence Techniques for the Non-invasive Detection of COVID-19 Through the Analysis of Voice Signals. Arabian Journal for Science and Engineering [https://doi.org/10.1007/s13369-021-06041-4](https://doi.org/10.1007/s13369-021-06041-4) (2021). 30. 30.World Health Organization. Tracking SARS-CoV-2 variants. [https://www.who.int/activities/tracking-SARS-CoV-2-variants](https://www.who.int/activities/tracking-SARS-CoV-2-variants) (2022). 31. 31.Centers for Disease Control and Prevention. Potential Rapid Increase of Omicron Variant Infections in the United States. [https://www.cdc.gov/coronavirus/2019-ncov/science/forecasting/mathematical-modeling-outbreak.html](https://www.cdc.gov/coronavirus/2019-ncov/science/forecasting/mathematical-modeling-outbreak.html) (2021). 32. 32.Centers for Disease Control and Prevention. Omicron Variant: What You Need to Know. [https://www.cdc.gov/coronavirus/2019-ncov/variants/Omicron-variant.html](https://www.cdc.gov/coronavirus/2019-ncov/variants/Omicron-variant.html) (2022). 33. 33.Centers for Disease Control and Prevention. COVID Data Tracker. [https://covid.cdc.gov/covid-data-tracker/#variant-proportions](https://covid.cdc.gov/covid-data-tracker/#variant-proportions) (2022). 34. 34.Dolby.io. Introduction to Media APIs. [https://docs.dolby.io/media-apis/docs](https://docs.dolby.io/media-apis/docs) (2022). 35. 35.Ronneberger, O., Fischer, P., & Brox, T. U-Net: Convolutional Networks for Biomedical Image Segmentation. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015, 234–241 (2015). 36. 36.Wiseman, J. Python interface to the Google WebRTC Voice Activity Detector (VAD). PyPI [https://pypi.org/project/webrtcvad/](https://pypi.org/project/webrtcvad/) (2017). 37. 37.Palanisamy, K., Singhania, D., & Yao, A. Rethinking CNN Models for Audio Classification. Preprint at arXiv [https://doi.org/10.48550/ARXIV.2007.11154](https://doi.org/10.48550/ARXIV.2007.11154) (2020). 38. 38.Aly, M., Rahouma, K. H., & Ramzy, S. M. Pay attention to the speech: COVID-19 diagnosis using machine learning and crowdsourced respiratory and speech recordings. Alexandria Engineering Journal 61(5), 3487– 3500 (2022). 39. 39.Park, D. S. et al. SpecAugment: A Simple Data Augmentation Method for Automatic Speech Recognition. Interspeech 2019 [https://doi.org/10.21437/interspeech.2019-2680](https://doi.org/10.21437/interspeech.2019-2680) (2019). 40. 40.Iandola, F. et al. DenseNet: Implementing Efficient ConvNet Descriptor Pyramids. Preprint at arXiv [https://doi.org/10.48550/ARXIV.1404.1869](https://doi.org/10.48550/ARXIV.1404.1869) (2014). 41. 41.Deng, J. et al. ImageNet: A large-scale hierarchical image database. 2009 IEEE Conference on Computer Vision and Pattern Recognition, 248–255 (2009). 42. 42.Dosovitskiy, A. et al. An Image is Worth 16×16 Words: Transformers for Image Recognition at Scale. Preprint at arXiv [https://doi.org/10.48550/ARXIV.2010.11929](https://doi.org/10.48550/ARXIV.2010.11929) (2020). 43. 43.Sutherland, M. E. Vocal pitch in the human brain. Nat Hum Behav 2, 613 (2018). 44. 44.Dichter, B. K., Breshears, J. D., Leonard, M. K., & Chang, E. F. The control of vocal pitch in human laryngeal motor cortex. Cell 174(1), 21–31 (2018). [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.cell.2018.05.016&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=29958109&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F06%2F2022.09.13.22279673.atom)